Loading...
Mutant calreticulin in myeloproliferative neoplasms
Recurrent mutations in calreticulin are present in ∼20% of patients with myeloproliferative neoplasms (MPNs). Since its discovery in 2013, we now have a more precise understanding of how mutant CALR, an endoplasmic reticulum chaperone protein, activates the JAK/STAT signaling pathway via a pathogeni...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6923668/ https://ncbi.nlm.nih.gov/pubmed/31562135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000622 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|